0001354457-21-000509.txt : 20210426
0001354457-21-000509.hdr.sgml : 20210426
20210426085228
ACCESSION NUMBER: 0001354457-21-000509
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERPACE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001054102
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 222919486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24249
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 412-224-6100
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Interpace Diagnostics Group, Inc.
DATE OF NAME CHANGE: 20151223
FORMER COMPANY:
FORMER CONFORMED NAME: PDI INC
DATE OF NAME CHANGE: 20021113
FORMER COMPANY:
FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC
DATE OF NAME CHANGE: 19980129
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001054102
INTERPACE BIOSCIENCES, INC.
000-24249
10 Mountainview Road
1 Route 17 South
Upper Saddle River
NJ
NEW JERSEY
07458
201-258-8450
Common stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2021-04-26
EX-99.25
2
idxgdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC,
April 26, 2021, Interpace Biosciences, Inc. The Nasdaq
Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of Interpace Biosciences, Inc.,
effective at the opening of the trading session on May 10, 2021.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5550(b).
The Company was notified of the Staff determination on
February 16, 2021. The Company did not appeal the Staff
determination to the Hearings Panel. The Listing Council
did not call the matter for review. The Staff determination
to delist the Company common stock became final on
February 25, 2021.